Genentech
American biotechnology corporation / From Wikipedia, the free encyclopedia
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.[5] Historically, the company is regarded as the world's first biotechnology company.[6]
Quick Facts Company type, Industry ...
Company type | Subsidiary |
---|---|
Industry | Biotechnology |
Founded | 1976; 48 years ago (1976) |
Headquarters | South San Francisco, California, United States |
Key people |
|
Products | Avastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Polivy, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax |
Revenue | $26.4 billion (2020)[4] |
Number of employees | 13,539 (July 2021) |
Parent | Roche |
Website | gene |
Close
As of July 2021, Genentech employed 13,539 people.[7]